Suppr超能文献

使用环孢素后肾移植术后感染发生率降低。

Decreased incidence of infection after renal transplantation with the use of cyclosporine.

作者信息

d'Ivernois C, Dupon M, Dartigues J F, Potaux L, Aparicio M, Lacut J Y

机构信息

Service de Maladies Infectieuses et Médecine Interne, Hôpital Pellegrin, Bordeaux, France.

出版信息

Eur J Clin Microbiol Infect Dis. 1991 Nov;10(11):911-6. doi: 10.1007/BF02005443.

Abstract

The incidence of infection within six months of cadaveric kidney transplantation was reviewed in 183 consecutive patients. Prior to June, 1985, 91 patients received azathioprine 2 mg/kg/day and prednisone 0.5 mg/kg/day; 63 patients (group A1) also received antilymphocyte globulin 15 mg/kg/day for the first ten days, whereas for the 28 other patients (group A2) antilymphocyte globulin had to be withdrawn before 72 hours because of general intolerance. The next 92 patients received cyclosporine 5-8 mg/kg/day and prednisone 0.25 mg/kg/day (group B). The three groups were similar for all studied parameters except for the number of patients with anti-HLA antibodies. At six months the mortality rate was not significantly different between the three groups. After six months the number of infections per patient was 1.47, 1.03 and 0.84 (p less than 0.01) in groups A1, A2 and B respectively; the percentage of patients developing one or more infections was 81, 58 and 57% (p less than 0.01); bacterial infections: 57, 50 and 34% (p less than 0.01); viral infections: 40, 14 and 10% (p less than 0.01); cytomegalovirus infections: 27, 11 and 4% (p less than 0.001). After adjustment with logistic regression upon factors which might facilitate infections, the results showed a significantly lower incidence of infection for the cyclosporine-treated group, especially for cytomegalovirus, as compared with the antilymphocyte globulin-treated group.

摘要

对183例接受尸体肾移植的连续患者进行了术后6个月内感染发生率的回顾性研究。1985年6月之前,91例患者接受硫唑嘌呤2mg/kg/天和泼尼松0.5mg/kg/天治疗;63例患者(A1组)在开始的10天还接受抗淋巴细胞球蛋白15mg/kg/天治疗,而另外28例患者(A2组)因全身不耐受在72小时内停用抗淋巴细胞球蛋白。接下来的92例患者接受环孢素5 - 8mg/kg/天和泼尼松0.25mg/kg/天治疗(B组)。除了抗HLA抗体阳性患者数量外,三组在所有研究参数方面均相似。6个月时,三组的死亡率无显著差异。6个月后,A1组、A2组和B组患者每人的感染次数分别为1.47、1.03和0.84(p<0.01);发生一次或多次感染的患者百分比分别为81%、58%和57%(p<0.01);细菌感染分别为57%、50%和34%(p<0.01);病毒感染分别为40%、14%和10%(p<0.01);巨细胞病毒感染分别为27%、11%和4%(p<0.001)。在对可能促进感染的因素进行逻辑回归调整后,结果显示与抗淋巴细胞球蛋白治疗组相比,环孢素治疗组的感染发生率显著降低,尤其是巨细胞病毒感染。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验